These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15934798)

  • 21. Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine.
    Dodick DW; Sandrini G; Williams P
    CNS Drugs; 2007; 21(1):73-82. PubMed ID: 17190530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spotlight on eletriptan in migraine.
    McCormack PL; Keating GM
    CNS Drugs; 2006; 20(11):961-4. PubMed ID: 17044732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study.
    Solomon S; Frishberg B; Hu XH; Markson L; Berger M
    Clin Ther; 2001 Jun; 23(6):886-900. PubMed ID: 11440288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.
    Pascual J; Mateos V; Roig C; Sanchez-Del-Rio M; Jiménez D
    Headache; 2007 Sep; 47(8):1152-68. PubMed ID: 17883520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
    Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
    Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine.
    Garcia-Ramos G; MacGregor EA; Hilliard B; Bordini CA; Leston J; Hettiarachchi J
    Cephalalgia; 2003 Nov; 23(9):869-76. PubMed ID: 14616928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pharmacoeconomic evaluation of oral triptans in the treatment of migraine in Italy.
    Gori S; Morelli N; Acuto G; Caiola F; Iudice A; Murri L
    Minerva Med; 2006 Dec; 97(6):467-77. PubMed ID: 17213783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
    Guidotti M; Ravasio R
    Clin Drug Investig; 2009; 29(11):693-702. PubMed ID: 19813772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
    Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
    Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders.
    Diamond ML; Hettiarachchi J; Hilliard B; Sands G; Nett R
    Headache; 2004 Mar; 44(3):209-16. PubMed ID: 15012657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of migraine in Canada with naratriptan: a cost-effectiveness analysis.
    Caro JJ; Getsios D; Raggio G; Caro G; Black L
    Headache; 2001 May; 41(5):456-64. PubMed ID: 11380643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of the use of triptans in acute migraine.
    Gawel MJ; Worthington I; Maggisano A
    Can J Neurol Sci; 2001 Feb; 28(1):30-41. PubMed ID: 11252291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal].
    Félix JM; Inês MS; Acosta CM
    Acta Med Port; 2005; 18(1):77-87. PubMed ID: 16202337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of oral triptan therapy in Sweden.
    Ramsberg J; Henriksson M
    Cephalalgia; 2007 Jan; 27(1):54-62. PubMed ID: 17212684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute treatment of migraine and the role of triptans.
    Freitag FG
    Curr Neurol Neurosci Rep; 2001 Mar; 1(2):125-32. PubMed ID: 11898508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of rizatriptan and sumatriptan versus Cafergot in the acute treatment of migraine.
    Zhang L; Hay JW
    CNS Drugs; 2005; 19(7):635-42. PubMed ID: 15984898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of eletriptan in triptan-naïve patients: results of a combined analysis.
    Martin VT; Valade D; Almas M; Hettiarachchi J; Sikes C; Albert KS; Parsons B
    Headache; 2007 Feb; 47(2):181-8. PubMed ID: 17300357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative sensitivity of stopwatch methodology and conventional pain assessment measures for detecting early response to triptans in migraine: results of a randomized, open-label pilot study.
    Sunshine A; Mulhern SA; Olson N; Elkind A; Almas M; Sikes C
    Clin Ther; 2006 Aug; 28(8):1107-1115. PubMed ID: 16982287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.